what is noom glp-1 companion Partners With Liviniti on Noom's Newest Offering: Noom Noom GLP-1 Review 2026: Great

GLP-1 Receptor Agonist Wegovy is a GLP-1 receptor agonist, a class of medication originally developed for type 2 diabetes and now prescribed for weight management

Beyond weight loss and diabetes, GLP-1 therapies are being studied for conditions such as: Alzheimers and Parkinsons disease Non-alcoholic fatty liver disease (NAFLD) Polycystic ovary syndrome (PCOS) Final Thoughts: GLP-1 as a Metabolic Game Changer GLP-1 is more than just a gut hormone

How most online medical weight loss programs work Virtual weight loss programs follow a similar general process, though the depth of support varies

But did you know that recent evidence shows these new drugs may do more than just help with weight loss and diabetes

However, these calculators dont replace clinical guidance

The medication helps manage the biological side of weight loss, like hunger signals and cravings, which gives you the headspace and energy to focus on nutrition and movement